S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
NASDAQ:ASNS

Arsanis (ASNS) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$2.65
▼
$3.23
50-Day Range
$3.11
▼
$3.11
52-Week Range
$1.15
▼
$28.69
Volume
31,653 shs
Average Volume
177,768 shs
Market Capitalization
$5.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

ASNS stock logo

About Arsanis (NASDAQ:ASNS) Stock

X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.

Receive ASNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arsanis and its competitors with MarketBeat's FREE daily newsletter.

ASNS Stock News Headlines

May 22, 2023 | finance.yahoo.com
Actelis To Present at the LD Micro Invitational XIII
May 18, 2023 | investing.com
Actelis Networks Inc (ASNS)
June 5, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
May 12, 2023 | finance.yahoo.com
Actelis Networks Reports Fiscal First Quarter 2023
May 8, 2023 | finance.yahoo.com
Actelis Networks Announces Closing of $3.5 Million Private Placement Priced At-the-Market under Nasdaq Rules
May 4, 2023 | finance.yahoo.com
Why Are Actelis Networks Shares Trading Higher Today
May 4, 2023 | finance.yahoo.com
Actelis Networks Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
May 3, 2023 | finance.yahoo.com
What's Happening With Actelis Networks Stock Today
June 5, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
May 3, 2023 | finance.yahoo.com
Actelis Networks Regains Compliance With Nasdaq Minimum Bid Price Requirement
May 1, 2023 | finance.yahoo.com
Actelis Networks Showcases New Hybrid Fiber-Copper Solutions Extending Gigabit Speed Connectivity For IoT Applications and 18 Million Multiple Dwelling Units
April 21, 2023 | benzinga.com
Actelis Networks Stock (NASDAQ:ASNS), Dividends
April 19, 2023 | finance.yahoo.com
Actelis Networks Announces 1-For-10 Reverse Stock Split to Aid Compliance With Nasdaq Listing Requirements
April 5, 2023 | finance.yahoo.com
City of West Sacramento Modernizes Traffic Management With Actelis’ Hybrid Fiber-Copper Solutions
March 29, 2023 | finance.yahoo.com
Actelis Networks Reports Fiscal Full Year 2022
March 22, 2023 | finance.yahoo.com
Actelis Networks to Report Fiscal Full Year 2022 Financial Results on Wednesday, March 29, 2023, at 4:30 p.m. ET
March 8, 2023 | finance.yahoo.com
Actelis Strengthens Global Footprint With Appointment Of New Asia-Pacific Regional Vice President
February 21, 2023 | finance.yahoo.com
Actelis Selected by the City of Eugene for Traffic Modernization Project
February 18, 2023 | benzinga.com
Actelis Networks Stock (NASDAQ:ASNS), Quotes and News Summary
January 13, 2023 | finance.yahoo.com
Actelis to Present at the Sidoti Virtual Conference on January 18th, 2023
January 3, 2023 | finance.yahoo.com
Actelis Selected By Northern Ireland Railways For Safety Critical Project
December 19, 2022 | finance.yahoo.com
Actelis Extends Cyber-Hardened, Fiber-Grade, Rapid Deployment Networking to On Base Facilities Using Existing Infrastructure
December 18, 2022 | reuters.com
Actelis Networks Inc
November 22, 2022 | finance.yahoo.com
Actelis Networks, Inc. Authorizes up to $1 Million Share Repurchase Program
November 12, 2022 | finance.yahoo.com
Actelis Networks Reports Third Quarter and First Nine Months of Fiscal 2022
November 4, 2022 | finance.yahoo.com
Actelis Networks to Report Fiscal Third Quarter 2022 Financial Results on Friday, November 11, 2022, at 4:30 p.m. ET
October 25, 2022 | finance.yahoo.com
Actelis Selects Norseman Defense Technologies As Its Latest US Government Focused Sales Partner
See More Headlines


ASNS Company Calendar

Last Earnings
11/09/2018
Today
6/04/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Communications equipment, not elsewhere classified
Sub-Industry
N/A
Sector
Computer and Technology
Current Symbol
NASDAQ:ASNS
CUSIP
N/A
CIK
1501697
Web
www.arsanis.com
Phone
(857) 529-8300
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($4.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,980,000.00
Net Margins
-93.50%
Pretax Margin
-93.50%
Return on Equity
-183.07%
Return on Assets
-52.55%

Debt

Debt-to-Equity Ratio
2.62
Current Ratio
1.03
Quick Ratio
0.83

Sales & Book Value

Annual Sales
$8.83 million
Price / Sales
0.63
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.73 per share
Price / Book
3.90

Miscellaneous

Outstanding Shares
1,940,000
Free Float
1,642,000
Market Cap
$5.53 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Paula S. Ragan
    President, Chief Executive Officer & Director
  • Adam S. Mostafa
    Chief Financial Officer & Treasurer
  • Celeste DiJohnson
    Vice President-Clinical Operations
  • Mary DiBiase
    Vice President-Technical Operations & Quality
  • Tarek Ebrahim
    Vice President-Medical Affairs & Rare Disease

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













ASNS Stock - Frequently Asked Questions

Are investors shorting Arsanis?

Arsanis saw a increase in short interest in May. As of May 15th, there was short interest totaling 52,800 shares, an increase of 214.3% from the April 30th total of 16,800 shares. Based on an average daily trading volume, of 241,300 shares, the days-to-cover ratio is presently 0.2 days. Currently, 4.0% of the company's shares are short sold.
View Arsanis' Short Interest.

When is Arsanis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our ASNS earnings forecast.

How were Arsanis' earnings last quarter?

Arsanis, Inc. (NASDAQ:ASNS) released its earnings results on Friday, November, 9th. The company reported ($7.60) EPS for the quarter, missing analysts' consensus estimates of ($7.40) by $0.20. Arsanis had a negative net margin of 93.50% and a negative trailing twelve-month return on equity of 183.07%.

When did Arsanis' stock split?

Arsanis shares reverse split on the morning of Wednesday, April 19th 2023. The 1-10 reverse split was announced on Wednesday, April 19th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Arsanis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Arsanis investors own include Catalyst Pharmaceuticals (CPRX), NxStage Medical (NXTM), Selecta Biosciences (SELB), CDTi Advanced Materials (CDTI), Curis (CRIS), bluebird bio (BLUE), Juno Therapeutics (JUNO), Nektar Therapeutics (NKTR), Protalix BioTherapeutics (PLX) and Tocagen (TOCA).

When did Arsanis IPO?

(ASNS) raised $15 million in an initial public offering on Friday, May 13th 2022. The company issued 3,000,000 shares at $4.00-$6.00 per share. Boustead Securities acted as the underwriter for the IPO.

What is Arsanis' stock symbol?

Arsanis trades on the NASDAQ under the ticker symbol "ASNS."

What is Arsanis' stock price today?

One share of ASNS stock can currently be purchased for approximately $2.85.

How much money does Arsanis make?

Arsanis (NASDAQ:ASNS) has a market capitalization of $5.53 million and generates $8.83 million in revenue each year. The company earns $-10,980,000.00 in net income (profit) each year or ($4.79) on an earnings per share basis.

How can I contact Arsanis?

Arsanis' mailing address is 890 WINTER STREET SUITE 230, WALTHAM MA, 02451. The official website for the company is www.arsanis.com. The company can be reached via phone at (857) 529-8300 or via email at ir@arsanis.com.

This page (NASDAQ:ASNS) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -